nodes	percent_of_prediction	percent_of_DWPC	metapath
Pimecrolimus—CYP3A4—Rivastigmine—Alzheimer's disease	0.153	0.432	CbGbCtD
Pimecrolimus—CYP3A4—Donepezil—Alzheimer's disease	0.122	0.345	CbGbCtD
Pimecrolimus—CYP3A4—Galantamine—Alzheimer's disease	0.0789	0.223	CbGbCtD
Pimecrolimus—Carcinoma colon—Rivastigmine—Alzheimer's disease	0.0486	0.135	CcSEcCtD
Pimecrolimus—Colon cancer—Rivastigmine—Alzheimer's disease	0.0351	0.0975	CcSEcCtD
Pimecrolimus—MTOR—blood vessel—Alzheimer's disease	0.00973	0.176	CbGeAlD
Pimecrolimus—Condition aggravated—Memantine—Alzheimer's disease	0.00941	0.0261	CcSEcCtD
Pimecrolimus—Laceration—Donepezil—Alzheimer's disease	0.00903	0.0251	CcSEcCtD
Pimecrolimus—Tacrolimus—PPP3CA—Alzheimer's disease	0.00821	0.895	CrCbGaD
Pimecrolimus—Application site burn—Rivastigmine—Alzheimer's disease	0.00802	0.0223	CcSEcCtD
Pimecrolimus—Squamous cell carcinoma—Memantine—Alzheimer's disease	0.00757	0.021	CcSEcCtD
Pimecrolimus—Basal cell carcinoma—Memantine—Alzheimer's disease	0.00729	0.0202	CcSEcCtD
Pimecrolimus—Basal cell carcinoma—Rivastigmine—Alzheimer's disease	0.00714	0.0198	CcSEcCtD
Pimecrolimus—Application site erythema—Rivastigmine—Alzheimer's disease	0.00714	0.0198	CcSEcCtD
Pimecrolimus—Application site pruritus—Rivastigmine—Alzheimer's disease	0.00689	0.0191	CcSEcCtD
Pimecrolimus—Application site irritation—Rivastigmine—Alzheimer's disease	0.00606	0.0168	CcSEcCtD
Pimecrolimus—MTOR—embryo—Alzheimer's disease	0.0058	0.105	CbGeAlD
Pimecrolimus—Skin cancer—Rivastigmine—Alzheimer's disease	0.00542	0.0151	CcSEcCtD
Pimecrolimus—Skin papilloma—Rivastigmine—Alzheimer's disease	0.00516	0.0143	CcSEcCtD
Pimecrolimus—MTOR—forebrain—Alzheimer's disease	0.00513	0.0929	CbGeAlD
Pimecrolimus—Non-Hodgkin's lymphoma—Memantine—Alzheimer's disease	0.00492	0.0137	CcSEcCtD
Pimecrolimus—Lymphoma—Memantine—Alzheimer's disease	0.00492	0.0137	CcSEcCtD
Pimecrolimus—MTOR—telencephalon—Alzheimer's disease	0.00472	0.0854	CbGeAlD
Pimecrolimus—FKBP1A—forebrain—Alzheimer's disease	0.00462	0.0835	CbGeAlD
Pimecrolimus—FKBP1A—telencephalon—Alzheimer's disease	0.00424	0.0768	CbGeAlD
Pimecrolimus—Application site pain—Rivastigmine—Alzheimer's disease	0.00382	0.0106	CcSEcCtD
Pimecrolimus—Bacterial infection—Memantine—Alzheimer's disease	0.00372	0.0103	CcSEcCtD
Pimecrolimus—Bacterial infection—Rivastigmine—Alzheimer's disease	0.00364	0.0101	CcSEcCtD
Pimecrolimus—Furuncle—Rivastigmine—Alzheimer's disease	0.00343	0.00951	CcSEcCtD
Pimecrolimus—Toothache—Donepezil—Alzheimer's disease	0.00311	0.00864	CcSEcCtD
Pimecrolimus—Toothache—Memantine—Alzheimer's disease	0.00283	0.00784	CcSEcCtD
Pimecrolimus—MTOR—nervous system—Alzheimer's disease	0.00279	0.0504	CbGeAlD
Pimecrolimus—MTOR—central nervous system—Alzheimer's disease	0.00268	0.0485	CbGeAlD
Pimecrolimus—Throat sore—Donepezil—Alzheimer's disease	0.00263	0.00729	CcSEcCtD
Pimecrolimus—MTOR—cerebellum—Alzheimer's disease	0.00262	0.0474	CbGeAlD
Pimecrolimus—Oropharyngeal discomfort—Donepezil—Alzheimer's disease	0.0026	0.00722	CcSEcCtD
Pimecrolimus—FKBP1A—nervous system—Alzheimer's disease	0.00251	0.0453	CbGeAlD
Pimecrolimus—Otitis media—Donepezil—Alzheimer's disease	0.00243	0.00675	CcSEcCtD
Pimecrolimus—FKBP1A—central nervous system—Alzheimer's disease	0.00241	0.0437	CbGeAlD
Pimecrolimus—FKBP1A—cerebellum—Alzheimer's disease	0.00236	0.0427	CbGeAlD
Pimecrolimus—Eye irritation—Donepezil—Alzheimer's disease	0.00222	0.00615	CcSEcCtD
Pimecrolimus—Otitis media—Memantine—Alzheimer's disease	0.00221	0.00613	CcSEcCtD
Pimecrolimus—Otitis media—Rivastigmine—Alzheimer's disease	0.00216	0.00599	CcSEcCtD
Pimecrolimus—MTOR—brain—Alzheimer's disease	0.00213	0.0385	CbGeAlD
Pimecrolimus—Skin discolouration—Donepezil—Alzheimer's disease	0.0021	0.00582	CcSEcCtD
Pimecrolimus—Oropharyngeal pain—Donepezil—Alzheimer's disease	0.00208	0.00578	CcSEcCtD
Pimecrolimus—Gastroenteritis—Galantamine—Alzheimer's disease	0.002	0.00555	CcSEcCtD
Pimecrolimus—Neoplasm malignant—Rivastigmine—Alzheimer's disease	0.00197	0.00546	CcSEcCtD
Pimecrolimus—FKBP1A—brain—Alzheimer's disease	0.00192	0.0347	CbGeAlD
Pimecrolimus—Bone disorder—Memantine—Alzheimer's disease	0.0019	0.00528	CcSEcCtD
Pimecrolimus—Bone disorder—Rivastigmine—Alzheimer's disease	0.00186	0.00517	CcSEcCtD
Pimecrolimus—Skin discolouration—Rivastigmine—Alzheimer's disease	0.00186	0.00517	CcSEcCtD
Pimecrolimus—Viral infection—Rivastigmine—Alzheimer's disease	0.00186	0.00517	CcSEcCtD
Pimecrolimus—Wheezing—Donepezil—Alzheimer's disease	0.00184	0.0051	CcSEcCtD
Pimecrolimus—Herpes simplex—Rivastigmine—Alzheimer's disease	0.00182	0.00506	CcSEcCtD
Pimecrolimus—Influenza like illness—Memantine—Alzheimer's disease	0.00167	0.00463	CcSEcCtD
Pimecrolimus—Skin exfoliation—Memantine—Alzheimer's disease	0.00164	0.00455	CcSEcCtD
Pimecrolimus—Influenza like illness—Rivastigmine—Alzheimer's disease	0.00163	0.00453	CcSEcCtD
Pimecrolimus—Abdominal pain upper—Galantamine—Alzheimer's disease	0.00162	0.00449	CcSEcCtD
Pimecrolimus—Ear pain—Donepezil—Alzheimer's disease	0.00161	0.00447	CcSEcCtD
Pimecrolimus—Skin exfoliation—Rivastigmine—Alzheimer's disease	0.00161	0.00446	CcSEcCtD
Pimecrolimus—Gastroenteritis—Donepezil—Alzheimer's disease	0.00155	0.0043	CcSEcCtD
Pimecrolimus—Bronchitis—Galantamine—Alzheimer's disease	0.00147	0.00409	CcSEcCtD
Pimecrolimus—Ear pain—Memantine—Alzheimer's disease	0.00146	0.00406	CcSEcCtD
Pimecrolimus—Ear pain—Rivastigmine—Alzheimer's disease	0.00143	0.00397	CcSEcCtD
Pimecrolimus—Upper respiratory tract infection—Galantamine—Alzheimer's disease	0.00142	0.00395	CcSEcCtD
Pimecrolimus—Gastroenteritis—Memantine—Alzheimer's disease	0.00141	0.00391	CcSEcCtD
Pimecrolimus—Gastroenteritis—Rivastigmine—Alzheimer's disease	0.00138	0.00382	CcSEcCtD
Pimecrolimus—Pneumonia—Galantamine—Alzheimer's disease	0.00137	0.00381	CcSEcCtD
Pimecrolimus—Face oedema—Donepezil—Alzheimer's disease	0.00133	0.00368	CcSEcCtD
Pimecrolimus—Epistaxis—Galantamine—Alzheimer's disease	0.00129	0.00358	CcSEcCtD
Pimecrolimus—Abdominal pain upper—Donepezil—Alzheimer's disease	0.00125	0.00348	CcSEcCtD
Pimecrolimus—Rhinitis—Galantamine—Alzheimer's disease	0.00123	0.00341	CcSEcCtD
Pimecrolimus—Nasopharyngitis—Donepezil—Alzheimer's disease	0.00123	0.00341	CcSEcCtD
Pimecrolimus—Influenza—Donepezil—Alzheimer's disease	0.00119	0.0033	CcSEcCtD
Pimecrolimus—Asthma—Donepezil—Alzheimer's disease	0.00119	0.0033	CcSEcCtD
Pimecrolimus—Face oedema—Rivastigmine—Alzheimer's disease	0.00118	0.00327	CcSEcCtD
Pimecrolimus—Eye disorder—Galantamine—Alzheimer's disease	0.00115	0.00318	CcSEcCtD
Pimecrolimus—Bronchitis—Donepezil—Alzheimer's disease	0.00114	0.00317	CcSEcCtD
Pimecrolimus—Flushing—Galantamine—Alzheimer's disease	0.00114	0.00316	CcSEcCtD
Pimecrolimus—Nasopharyngitis—Memantine—Alzheimer's disease	0.00112	0.0031	CcSEcCtD
Pimecrolimus—Abdominal pain upper—Rivastigmine—Alzheimer's disease	0.00111	0.00309	CcSEcCtD
Pimecrolimus—Immune system disorder—Galantamine—Alzheimer's disease	0.00111	0.00307	CcSEcCtD
Pimecrolimus—Breast disorder—Rivastigmine—Alzheimer's disease	0.0011	0.00306	CcSEcCtD
Pimecrolimus—Nasopharyngitis—Rivastigmine—Alzheimer's disease	0.00109	0.00303	CcSEcCtD
Pimecrolimus—Asthma—Memantine—Alzheimer's disease	0.00108	0.00299	CcSEcCtD
Pimecrolimus—Influenza—Memantine—Alzheimer's disease	0.00108	0.00299	CcSEcCtD
Pimecrolimus—Malnutrition—Galantamine—Alzheimer's disease	0.00107	0.00296	CcSEcCtD
Pimecrolimus—Pneumonia—Donepezil—Alzheimer's disease	0.00107	0.00296	CcSEcCtD
Pimecrolimus—Infestation—Donepezil—Alzheimer's disease	0.00106	0.00294	CcSEcCtD
Pimecrolimus—Infestation NOS—Donepezil—Alzheimer's disease	0.00106	0.00294	CcSEcCtD
Pimecrolimus—Bronchitis—Memantine—Alzheimer's disease	0.00104	0.00288	CcSEcCtD
Pimecrolimus—Back pain—Galantamine—Alzheimer's disease	0.00103	0.00287	CcSEcCtD
Pimecrolimus—Conjunctivitis—Donepezil—Alzheimer's disease	0.00103	0.00286	CcSEcCtD
Pimecrolimus—Bronchitis—Rivastigmine—Alzheimer's disease	0.00101	0.00282	CcSEcCtD
Pimecrolimus—Upper respiratory tract infection—Memantine—Alzheimer's disease	0.001	0.00278	CcSEcCtD
Pimecrolimus—Epistaxis—Donepezil—Alzheimer's disease	0.000999	0.00277	CcSEcCtD
Pimecrolimus—Upper respiratory tract infection—Rivastigmine—Alzheimer's disease	0.00098	0.00272	CcSEcCtD
Pimecrolimus—Pneumonia—Memantine—Alzheimer's disease	0.000967	0.00268	CcSEcCtD
Pimecrolimus—Photosensitivity reaction—Rivastigmine—Alzheimer's disease	0.000963	0.00267	CcSEcCtD
Pimecrolimus—Infestation NOS—Memantine—Alzheimer's disease	0.000961	0.00267	CcSEcCtD
Pimecrolimus—Infestation—Memantine—Alzheimer's disease	0.000961	0.00267	CcSEcCtD
Pimecrolimus—Temsirolimus—CYP2D6—Alzheimer's disease	0.000961	0.105	CrCbGaD
Pimecrolimus—Rhinitis—Donepezil—Alzheimer's disease	0.000953	0.00264	CcSEcCtD
Pimecrolimus—Pneumonia—Rivastigmine—Alzheimer's disease	0.000946	0.00263	CcSEcCtD
Pimecrolimus—Pharyngitis—Donepezil—Alzheimer's disease	0.000943	0.00262	CcSEcCtD
Pimecrolimus—Infestation NOS—Rivastigmine—Alzheimer's disease	0.000941	0.00261	CcSEcCtD
Pimecrolimus—Infestation—Rivastigmine—Alzheimer's disease	0.000941	0.00261	CcSEcCtD
Pimecrolimus—Conjunctivitis—Memantine—Alzheimer's disease	0.000935	0.00259	CcSEcCtD
Pimecrolimus—Cough—Galantamine—Alzheimer's disease	0.000932	0.00259	CcSEcCtD
Pimecrolimus—Conjunctivitis—Rivastigmine—Alzheimer's disease	0.000914	0.00254	CcSEcCtD
Pimecrolimus—Arthralgia—Galantamine—Alzheimer's disease	0.000909	0.00252	CcSEcCtD
Pimecrolimus—Epistaxis—Memantine—Alzheimer's disease	0.000907	0.00252	CcSEcCtD
Pimecrolimus—Unspecified disorder of skin and subcutaneous tissue—Galantamine—Alzheimer's disease	0.000903	0.00251	CcSEcCtD
Pimecrolimus—Sinusitis—Memantine—Alzheimer's disease	0.000902	0.0025	CcSEcCtD
Pimecrolimus—Epistaxis—Rivastigmine—Alzheimer's disease	0.000887	0.00246	CcSEcCtD
Pimecrolimus—Sinusitis—Rivastigmine—Alzheimer's disease	0.000882	0.00245	CcSEcCtD
Pimecrolimus—Rhinitis—Memantine—Alzheimer's disease	0.000865	0.0024	CcSEcCtD
Pimecrolimus—Pharyngitis—Memantine—Alzheimer's disease	0.000857	0.00238	CcSEcCtD
Pimecrolimus—Nervous system disorder—Galantamine—Alzheimer's disease	0.000855	0.00237	CcSEcCtD
Pimecrolimus—Rhinitis—Rivastigmine—Alzheimer's disease	0.000846	0.00235	CcSEcCtD
Pimecrolimus—Skin disorder—Galantamine—Alzheimer's disease	0.000846	0.00235	CcSEcCtD
Pimecrolimus—Pharyngitis—Rivastigmine—Alzheimer's disease	0.000838	0.00233	CcSEcCtD
Pimecrolimus—Erythema—Donepezil—Alzheimer's disease	0.000827	0.0023	CcSEcCtD
Pimecrolimus—Malnutrition—Donepezil—Alzheimer's disease	0.000827	0.0023	CcSEcCtD
Pimecrolimus—CYP3A4—nervous system—Alzheimer's disease	0.000819	0.0148	CbGeAlD
Pimecrolimus—Eye disorder—Memantine—Alzheimer's disease	0.000807	0.00224	CcSEcCtD
Pimecrolimus—Flushing—Memantine—Alzheimer's disease	0.000801	0.00222	CcSEcCtD
Pimecrolimus—Back pain—Donepezil—Alzheimer's disease	0.0008	0.00222	CcSEcCtD
Pimecrolimus—Musculoskeletal discomfort—Galantamine—Alzheimer's disease	0.000794	0.0022	CcSEcCtD
Pimecrolimus—Eye disorder—Rivastigmine—Alzheimer's disease	0.000789	0.00219	CcSEcCtD
Pimecrolimus—CYP3A4—central nervous system—Alzheimer's disease	0.000788	0.0143	CbGeAlD
Pimecrolimus—Flushing—Rivastigmine—Alzheimer's disease	0.000784	0.00217	CcSEcCtD
Pimecrolimus—Paraesthesia—Galantamine—Alzheimer's disease	0.000782	0.00217	CcSEcCtD
Pimecrolimus—Immune system disorder—Memantine—Alzheimer's disease	0.00078	0.00216	CcSEcCtD
Pimecrolimus—Mediastinal disorder—Memantine—Alzheimer's disease	0.000778	0.00216	CcSEcCtD
Pimecrolimus—Mediastinal disorder—Rivastigmine—Alzheimer's disease	0.000761	0.00211	CcSEcCtD
Pimecrolimus—Gastrointestinal disorder—Galantamine—Alzheimer's disease	0.000752	0.00209	CcSEcCtD
Pimecrolimus—Malnutrition—Memantine—Alzheimer's disease	0.000751	0.00209	CcSEcCtD
Pimecrolimus—Constipation—Galantamine—Alzheimer's disease	0.000745	0.00207	CcSEcCtD
Pimecrolimus—Malnutrition—Rivastigmine—Alzheimer's disease	0.000735	0.00204	CcSEcCtD
Pimecrolimus—Erythema—Rivastigmine—Alzheimer's disease	0.000735	0.00204	CcSEcCtD
Pimecrolimus—Back pain—Memantine—Alzheimer's disease	0.000727	0.00202	CcSEcCtD
Pimecrolimus—Cough—Donepezil—Alzheimer's disease	0.000722	0.002	CcSEcCtD
Pimecrolimus—Gastrointestinal pain—Galantamine—Alzheimer's disease	0.000713	0.00198	CcSEcCtD
Pimecrolimus—Back pain—Rivastigmine—Alzheimer's disease	0.000711	0.00197	CcSEcCtD
Pimecrolimus—Arthralgia—Donepezil—Alzheimer's disease	0.000704	0.00196	CcSEcCtD
Pimecrolimus—Abdominal pain—Galantamine—Alzheimer's disease	0.000689	0.00191	CcSEcCtD
Pimecrolimus—Body temperature increased—Galantamine—Alzheimer's disease	0.000689	0.00191	CcSEcCtD
Pimecrolimus—Oedema—Donepezil—Alzheimer's disease	0.000675	0.00187	CcSEcCtD
Pimecrolimus—Infection—Donepezil—Alzheimer's disease	0.000671	0.00186	CcSEcCtD
Pimecrolimus—Nervous system disorder—Donepezil—Alzheimer's disease	0.000662	0.00184	CcSEcCtD
Pimecrolimus—Cough—Memantine—Alzheimer's disease	0.000656	0.00182	CcSEcCtD
Pimecrolimus—Hypersensitivity—Galantamine—Alzheimer's disease	0.000642	0.00178	CcSEcCtD
Pimecrolimus—Cough—Rivastigmine—Alzheimer's disease	0.000641	0.00178	CcSEcCtD
Pimecrolimus—Arthralgia—Memantine—Alzheimer's disease	0.00064	0.00178	CcSEcCtD
Pimecrolimus—Arthralgia—Rivastigmine—Alzheimer's disease	0.000626	0.00174	CcSEcCtD
Pimecrolimus—Unspecified disorder of skin and subcutaneous tissue—Rivastigmine—Alzheimer's disease	0.000621	0.00172	CcSEcCtD
Pimecrolimus—Musculoskeletal discomfort—Donepezil—Alzheimer's disease	0.000615	0.00171	CcSEcCtD
Pimecrolimus—Oedema—Memantine—Alzheimer's disease	0.000613	0.0017	CcSEcCtD
Pimecrolimus—Infection—Memantine—Alzheimer's disease	0.000609	0.00169	CcSEcCtD
Pimecrolimus—Paraesthesia—Donepezil—Alzheimer's disease	0.000606	0.00168	CcSEcCtD
Pimecrolimus—Dyspnoea—Donepezil—Alzheimer's disease	0.000602	0.00167	CcSEcCtD
Pimecrolimus—Nervous system disorder—Memantine—Alzheimer's disease	0.000601	0.00167	CcSEcCtD
Pimecrolimus—Oedema—Rivastigmine—Alzheimer's disease	0.0006	0.00166	CcSEcCtD
Pimecrolimus—Diarrhoea—Galantamine—Alzheimer's disease	0.000596	0.00165	CcSEcCtD
Pimecrolimus—Infection—Rivastigmine—Alzheimer's disease	0.000596	0.00165	CcSEcCtD
Pimecrolimus—Skin disorder—Memantine—Alzheimer's disease	0.000596	0.00165	CcSEcCtD
Pimecrolimus—Nervous system disorder—Rivastigmine—Alzheimer's disease	0.000588	0.00163	CcSEcCtD
Pimecrolimus—Gastrointestinal disorder—Donepezil—Alzheimer's disease	0.000583	0.00162	CcSEcCtD
Pimecrolimus—Skin disorder—Rivastigmine—Alzheimer's disease	0.000583	0.00162	CcSEcCtD
Pimecrolimus—Constipation—Donepezil—Alzheimer's disease	0.000578	0.0016	CcSEcCtD
Pimecrolimus—Pain—Donepezil—Alzheimer's disease	0.000578	0.0016	CcSEcCtD
Pimecrolimus—Musculoskeletal discomfort—Memantine—Alzheimer's disease	0.000559	0.00155	CcSEcCtD
Pimecrolimus—Vomiting—Galantamine—Alzheimer's disease	0.000554	0.00154	CcSEcCtD
Pimecrolimus—Gastrointestinal pain—Donepezil—Alzheimer's disease	0.000552	0.00153	CcSEcCtD
Pimecrolimus—Paraesthesia—Memantine—Alzheimer's disease	0.000551	0.00153	CcSEcCtD
Pimecrolimus—Rash—Galantamine—Alzheimer's disease	0.000549	0.00152	CcSEcCtD
Pimecrolimus—Dermatitis—Galantamine—Alzheimer's disease	0.000549	0.00152	CcSEcCtD
Pimecrolimus—Dyspnoea—Memantine—Alzheimer's disease	0.000547	0.00152	CcSEcCtD
Pimecrolimus—Musculoskeletal discomfort—Rivastigmine—Alzheimer's disease	0.000547	0.00152	CcSEcCtD
Pimecrolimus—Headache—Galantamine—Alzheimer's disease	0.000546	0.00152	CcSEcCtD
Pimecrolimus—Paraesthesia—Rivastigmine—Alzheimer's disease	0.000539	0.00149	CcSEcCtD
Pimecrolimus—Urticaria—Donepezil—Alzheimer's disease	0.000537	0.00149	CcSEcCtD
Pimecrolimus—Dyspnoea—Rivastigmine—Alzheimer's disease	0.000535	0.00148	CcSEcCtD
Pimecrolimus—Body temperature increased—Donepezil—Alzheimer's disease	0.000534	0.00148	CcSEcCtD
Pimecrolimus—Abdominal pain—Donepezil—Alzheimer's disease	0.000534	0.00148	CcSEcCtD
Pimecrolimus—Gastrointestinal disorder—Memantine—Alzheimer's disease	0.000529	0.00147	CcSEcCtD
Pimecrolimus—Pain—Memantine—Alzheimer's disease	0.000524	0.00146	CcSEcCtD
Pimecrolimus—Constipation—Memantine—Alzheimer's disease	0.000524	0.00146	CcSEcCtD
Pimecrolimus—Gastrointestinal disorder—Rivastigmine—Alzheimer's disease	0.000518	0.00144	CcSEcCtD
Pimecrolimus—Nausea—Galantamine—Alzheimer's disease	0.000518	0.00144	CcSEcCtD
Pimecrolimus—Pain—Rivastigmine—Alzheimer's disease	0.000513	0.00142	CcSEcCtD
Pimecrolimus—Constipation—Rivastigmine—Alzheimer's disease	0.000513	0.00142	CcSEcCtD
Pimecrolimus—Gastrointestinal pain—Memantine—Alzheimer's disease	0.000501	0.00139	CcSEcCtD
Pimecrolimus—Hypersensitivity—Donepezil—Alzheimer's disease	0.000498	0.00138	CcSEcCtD
Pimecrolimus—Gastrointestinal pain—Rivastigmine—Alzheimer's disease	0.000491	0.00136	CcSEcCtD
Pimecrolimus—Urticaria—Memantine—Alzheimer's disease	0.000487	0.00135	CcSEcCtD
Pimecrolimus—Body temperature increased—Memantine—Alzheimer's disease	0.000485	0.00135	CcSEcCtD
Pimecrolimus—Abdominal pain—Memantine—Alzheimer's disease	0.000485	0.00135	CcSEcCtD
Pimecrolimus—Pruritus—Donepezil—Alzheimer's disease	0.000478	0.00133	CcSEcCtD
Pimecrolimus—Urticaria—Rivastigmine—Alzheimer's disease	0.000477	0.00132	CcSEcCtD
Pimecrolimus—Body temperature increased—Rivastigmine—Alzheimer's disease	0.000474	0.00132	CcSEcCtD
Pimecrolimus—Abdominal pain—Rivastigmine—Alzheimer's disease	0.000474	0.00132	CcSEcCtD
Pimecrolimus—Diarrhoea—Donepezil—Alzheimer's disease	0.000462	0.00128	CcSEcCtD
Pimecrolimus—Hypersensitivity—Memantine—Alzheimer's disease	0.000452	0.00125	CcSEcCtD
Pimecrolimus—Hypersensitivity—Rivastigmine—Alzheimer's disease	0.000442	0.00123	CcSEcCtD
Pimecrolimus—Pruritus—Memantine—Alzheimer's disease	0.000434	0.0012	CcSEcCtD
Pimecrolimus—Vomiting—Donepezil—Alzheimer's disease	0.000429	0.00119	CcSEcCtD
Pimecrolimus—Rash—Donepezil—Alzheimer's disease	0.000426	0.00118	CcSEcCtD
Pimecrolimus—Dermatitis—Donepezil—Alzheimer's disease	0.000425	0.00118	CcSEcCtD
Pimecrolimus—Pruritus—Rivastigmine—Alzheimer's disease	0.000424	0.00118	CcSEcCtD
Pimecrolimus—Headache—Donepezil—Alzheimer's disease	0.000423	0.00117	CcSEcCtD
Pimecrolimus—Diarrhoea—Memantine—Alzheimer's disease	0.00042	0.00116	CcSEcCtD
Pimecrolimus—Diarrhoea—Rivastigmine—Alzheimer's disease	0.00041	0.00114	CcSEcCtD
Pimecrolimus—Nausea—Donepezil—Alzheimer's disease	0.000401	0.00111	CcSEcCtD
Pimecrolimus—Vomiting—Memantine—Alzheimer's disease	0.00039	0.00108	CcSEcCtD
Pimecrolimus—Rash—Memantine—Alzheimer's disease	0.000387	0.00107	CcSEcCtD
Pimecrolimus—Dermatitis—Memantine—Alzheimer's disease	0.000386	0.00107	CcSEcCtD
Pimecrolimus—Headache—Memantine—Alzheimer's disease	0.000384	0.00107	CcSEcCtD
Pimecrolimus—Vomiting—Rivastigmine—Alzheimer's disease	0.000381	0.00106	CcSEcCtD
Pimecrolimus—Rash—Rivastigmine—Alzheimer's disease	0.000378	0.00105	CcSEcCtD
Pimecrolimus—Dermatitis—Rivastigmine—Alzheimer's disease	0.000378	0.00105	CcSEcCtD
Pimecrolimus—Headache—Rivastigmine—Alzheimer's disease	0.000376	0.00104	CcSEcCtD
Pimecrolimus—Nausea—Memantine—Alzheimer's disease	0.000364	0.00101	CcSEcCtD
Pimecrolimus—Nausea—Rivastigmine—Alzheimer's disease	0.000356	0.000989	CcSEcCtD
Pimecrolimus—CYP3A4—Biological oxidations—CYP2D6—Alzheimer's disease	8.65e-05	0.000392	CbGpPWpGaD
Pimecrolimus—MTOR—Disease—GAPDH—Alzheimer's disease	8.62e-05	0.000391	CbGpPWpGaD
Pimecrolimus—CYP3A4—Metapathway biotransformation—CYP2D6—Alzheimer's disease	8.53e-05	0.000386	CbGpPWpGaD
Pimecrolimus—FKBP1A—Signaling Pathways—NPS—Alzheimer's disease	8.45e-05	0.000383	CbGpPWpGaD
Pimecrolimus—MTOR—Integrated Breast Cancer Pathway—TP53—Alzheimer's disease	8.42e-05	0.000381	CbGpPWpGaD
Pimecrolimus—FKBP1A—Signaling Pathways—PPP3CA—Alzheimer's disease	8.41e-05	0.000381	CbGpPWpGaD
Pimecrolimus—MTOR—Innate Immune System—MEF2C—Alzheimer's disease	8.35e-05	0.000378	CbGpPWpGaD
Pimecrolimus—FKBP1A—Signaling Pathways—PTK2B—Alzheimer's disease	8.29e-05	0.000376	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling Pathways—CDK5—Alzheimer's disease	8.28e-05	0.000375	CbGpPWpGaD
Pimecrolimus—MTOR—Innate Immune System—AGER—Alzheimer's disease	8.28e-05	0.000375	CbGpPWpGaD
Pimecrolimus—MTOR—Innate Immune System—PRKCG—Alzheimer's disease	8.19e-05	0.000371	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling by SCF-KIT—IL6—Alzheimer's disease	8.14e-05	0.000369	CbGpPWpGaD
Pimecrolimus—MTOR—Disease—PSEN2—Alzheimer's disease	8.07e-05	0.000365	CbGpPWpGaD
Pimecrolimus—FKBP1A—Signaling Pathways—GAB2—Alzheimer's disease	8.06e-05	0.000365	CbGpPWpGaD
Pimecrolimus—FKBP1A—Signaling Pathways—NTRK2—Alzheimer's disease	8.06e-05	0.000365	CbGpPWpGaD
Pimecrolimus—FKBP1A—Signaling Pathways—SST—Alzheimer's disease	8.06e-05	0.000365	CbGpPWpGaD
Pimecrolimus—FKBP1A—Disease—LPL—Alzheimer's disease	8.05e-05	0.000365	CbGpPWpGaD
Pimecrolimus—FKBP1A—Signaling Pathways—GSK3A—Alzheimer's disease	7.99e-05	0.000362	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling Pathways—HTR6—Alzheimer's disease	7.97e-05	0.000361	CbGpPWpGaD
Pimecrolimus—MTOR—Disease—CST3—Alzheimer's disease	7.89e-05	0.000357	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling by NGF—CASP3—Alzheimer's disease	7.87e-05	0.000357	CbGpPWpGaD
Pimecrolimus—FKBP1A—Signaling Pathways—APP—Alzheimer's disease	7.86e-05	0.000356	CbGpPWpGaD
Pimecrolimus—FKBP1A—Disease—PRKCG—Alzheimer's disease	7.83e-05	0.000355	CbGpPWpGaD
Pimecrolimus—MTOR—Downstream signaling of activated FGFR—IL6—Alzheimer's disease	7.79e-05	0.000353	CbGpPWpGaD
Pimecrolimus—MTOR—Immune System—INPP5D—Alzheimer's disease	7.76e-05	0.000351	CbGpPWpGaD
Pimecrolimus—MTOR—Cellular responses to stress—MAPK8—Alzheimer's disease	7.72e-05	0.00035	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling by ERBB4—IL6—Alzheimer's disease	7.66e-05	0.000347	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling by SCF-KIT—AKT1—Alzheimer's disease	7.51e-05	0.00034	CbGpPWpGaD
Pimecrolimus—MTOR—Immune System—CTSB—Alzheimer's disease	7.47e-05	0.000338	CbGpPWpGaD
Pimecrolimus—MTOR—Immune System—CTSD—Alzheimer's disease	7.43e-05	0.000337	CbGpPWpGaD
Pimecrolimus—FKBP1A—Disease—CCR5—Alzheimer's disease	7.42e-05	0.000336	CbGpPWpGaD
Pimecrolimus—FKBP1A—Signaling Pathways—PLCB1—Alzheimer's disease	7.42e-05	0.000336	CbGpPWpGaD
Pimecrolimus—MTOR—BDNF signaling pathway—AKT1—Alzheimer's disease	7.38e-05	0.000334	CbGpPWpGaD
Pimecrolimus—MTOR—Disease—IAPP—Alzheimer's disease	7.38e-05	0.000334	CbGpPWpGaD
Pimecrolimus—MTOR—Downstream signal transduction—IL6—Alzheimer's disease	7.32e-05	0.000332	CbGpPWpGaD
Pimecrolimus—MTOR—Immune System—PPP3CA—Alzheimer's disease	7.32e-05	0.000332	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling by FGFR—IL6—Alzheimer's disease	7.28e-05	0.00033	CbGpPWpGaD
Pimecrolimus—FKBP1A—Disease—MTHFR—Alzheimer's disease	7.25e-05	0.000329	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling by ERBB2—IL6—Alzheimer's disease	7.25e-05	0.000328	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling by NGF—MAPK8—Alzheimer's disease	7.24e-05	0.000328	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling Pathways—PSENEN—Alzheimer's disease	7.24e-05	0.000328	CbGpPWpGaD
Pimecrolimus—MTOR—Immune System—PTK2B—Alzheimer's disease	7.21e-05	0.000327	CbGpPWpGaD
Pimecrolimus—MTOR—DAP12 signaling—IL6—Alzheimer's disease	7.21e-05	0.000327	CbGpPWpGaD
Pimecrolimus—MTOR—Downstream signaling of activated FGFR—AKT1—Alzheimer's disease	7.18e-05	0.000325	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling Pathways—APH1A—Alzheimer's disease	7.13e-05	0.000323	CbGpPWpGaD
Pimecrolimus—MTOR—Cellular responses to stress—VEGFA—Alzheimer's disease	7.12e-05	0.000323	CbGpPWpGaD
Pimecrolimus—MTOR—Integrated Breast Cancer Pathway—AKT1—Alzheimer's disease	7.11e-05	0.000322	CbGpPWpGaD
Pimecrolimus—MTOR—Innate Immune System—CALM1—Alzheimer's disease	7.09e-05	0.000321	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling by ERBB4—AKT1—Alzheimer's disease	7.07e-05	0.00032	CbGpPWpGaD
Pimecrolimus—MTOR—Immune System—GAB2—Alzheimer's disease	7.01e-05	0.000318	CbGpPWpGaD
Pimecrolimus—MTOR—Immune System—GSK3A—Alzheimer's disease	6.95e-05	0.000315	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling Pathways—NCSTN—Alzheimer's disease	6.95e-05	0.000315	CbGpPWpGaD
Pimecrolimus—FKBP1A—Signaling Pathways—NGFR—Alzheimer's disease	6.92e-05	0.000313	CbGpPWpGaD
Pimecrolimus—MTOR—Immune System—APP—Alzheimer's disease	6.84e-05	0.00031	CbGpPWpGaD
Pimecrolimus—MTOR—Adaptive Immune System—CALM1—Alzheimer's disease	6.8e-05	0.000308	CbGpPWpGaD
Pimecrolimus—MTOR—Disease—ENO1—Alzheimer's disease	6.79e-05	0.000308	CbGpPWpGaD
Pimecrolimus—MTOR—Insulin Signaling—AKT1—Alzheimer's disease	6.78e-05	0.000307	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling by FGFR in disease—IL6—Alzheimer's disease	6.78e-05	0.000307	CbGpPWpGaD
Pimecrolimus—MTOR—DAP12 interactions—IL6—Alzheimer's disease	6.78e-05	0.000307	CbGpPWpGaD
Pimecrolimus—MTOR—Fc epsilon receptor (FCERI) signaling—IL6—Alzheimer's disease	6.78e-05	0.000307	CbGpPWpGaD
Pimecrolimus—FKBP1A—Disease—CALM1—Alzheimer's disease	6.78e-05	0.000307	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling Pathways—LRP1—Alzheimer's disease	6.77e-05	0.000307	CbGpPWpGaD
Pimecrolimus—FKBP1A—Signaling Pathways—ADAM10—Alzheimer's disease	6.76e-05	0.000306	CbGpPWpGaD
Pimecrolimus—MTOR—Disease—PPP3CA—Alzheimer's disease	6.76e-05	0.000306	CbGpPWpGaD
Pimecrolimus—FKBP1A—Disease—APOE—Alzheimer's disease	6.75e-05	0.000306	CbGpPWpGaD
Pimecrolimus—MTOR—Downstream signal transduction—AKT1—Alzheimer's disease	6.75e-05	0.000306	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling by EGFR—IL6—Alzheimer's disease	6.72e-05	0.000305	CbGpPWpGaD
Pimecrolimus—MTOR—EGF/EGFR Signaling Pathway—AKT1—Alzheimer's disease	6.72e-05	0.000304	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling by FGFR—AKT1—Alzheimer's disease	6.72e-05	0.000304	CbGpPWpGaD
Pimecrolimus—FKBP1A—Disease—CAV1—Alzheimer's disease	6.69e-05	0.000303	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling by ERBB2—AKT1—Alzheimer's disease	6.68e-05	0.000303	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling by EGFR in Cancer—IL6—Alzheimer's disease	6.66e-05	0.000302	CbGpPWpGaD
Pimecrolimus—MTOR—DAP12 signaling—AKT1—Alzheimer's disease	6.65e-05	0.000301	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling by PDGF—IL6—Alzheimer's disease	6.63e-05	0.000301	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling Pathways—GFAP—Alzheimer's disease	6.62e-05	0.0003	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling Pathways—GAL—Alzheimer's disease	6.62e-05	0.0003	CbGpPWpGaD
Pimecrolimus—MTOR—Downstream signaling events of B Cell Receptor (BCR)—AKT1—Alzheimer's disease	6.56e-05	0.000297	CbGpPWpGaD
Pimecrolimus—MTOR—Disease—GAB2—Alzheimer's disease	6.48e-05	0.000293	CbGpPWpGaD
Pimecrolimus—MTOR—Disease—GSK3A—Alzheimer's disease	6.42e-05	0.000291	CbGpPWpGaD
Pimecrolimus—FKBP1A—Signaling Pathways—S100B—Alzheimer's disease	6.39e-05	0.00029	CbGpPWpGaD
Pimecrolimus—MTOR—Disease—APP—Alzheimer's disease	6.31e-05	0.000286	CbGpPWpGaD
Pimecrolimus—FKBP1A—Disease—NOS2—Alzheimer's disease	6.29e-05	0.000285	CbGpPWpGaD
Pimecrolimus—MTOR—Fc epsilon receptor (FCERI) signaling—AKT1—Alzheimer's disease	6.26e-05	0.000284	CbGpPWpGaD
Pimecrolimus—MTOR—DAP12 interactions—AKT1—Alzheimer's disease	6.26e-05	0.000284	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling by FGFR in disease—AKT1—Alzheimer's disease	6.26e-05	0.000284	CbGpPWpGaD
Pimecrolimus—FKBP1A—Disease—NOTCH1—Alzheimer's disease	6.23e-05	0.000282	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling by EGFR—AKT1—Alzheimer's disease	6.2e-05	0.000281	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling by EGFR in Cancer—AKT1—Alzheimer's disease	6.15e-05	0.000279	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling by PDGF—AKT1—Alzheimer's disease	6.12e-05	0.000277	CbGpPWpGaD
Pimecrolimus—MTOR—Innate Immune System—GSK3B—Alzheimer's disease	6.11e-05	0.000277	CbGpPWpGaD
Pimecrolimus—FKBP1A—Signaling Pathways—IGF2—Alzheimer's disease	6.08e-05	0.000276	CbGpPWpGaD
Pimecrolimus—MTOR—Innate Immune System—CREB1—Alzheimer's disease	6.07e-05	0.000275	CbGpPWpGaD
Pimecrolimus—MTOR—NGF signalling via TRKA from the plasma membrane—IL6—Alzheimer's disease	6.01e-05	0.000272	CbGpPWpGaD
Pimecrolimus—FKBP1A—Signaling Pathways—IGF1R—Alzheimer's disease	5.88e-05	0.000267	CbGpPWpGaD
Pimecrolimus—MTOR—Adaptive Immune System—GSK3B—Alzheimer's disease	5.87e-05	0.000266	CbGpPWpGaD
Pimecrolimus—FKBP1A—Disease—GSK3B—Alzheimer's disease	5.85e-05	0.000265	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling Pathways—A2M—Alzheimer's disease	5.83e-05	0.000264	CbGpPWpGaD
Pimecrolimus—MTOR—Adaptive Immune System—CREB1—Alzheimer's disease	5.82e-05	0.000264	CbGpPWpGaD
Pimecrolimus—FKBP1A—Disease—CREB1—Alzheimer's disease	5.8e-05	0.000263	CbGpPWpGaD
Pimecrolimus—MTOR—B Cell Activation—AKT1—Alzheimer's disease	5.79e-05	0.000262	CbGpPWpGaD
Pimecrolimus—FKBP1A—Disease—INS—Alzheimer's disease	5.77e-05	0.000261	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling Pathways—PSEN2—Alzheimer's disease	5.65e-05	0.000256	CbGpPWpGaD
Pimecrolimus—FKBP1A—Signaling Pathways—LPL—Alzheimer's disease	5.64e-05	0.000256	CbGpPWpGaD
Pimecrolimus—FKBP1A—Signaling Pathways—MEF2C—Alzheimer's disease	5.59e-05	0.000253	CbGpPWpGaD
Pimecrolimus—MTOR—Immune System—S100B—Alzheimer's disease	5.56e-05	0.000252	CbGpPWpGaD
Pimecrolimus—MTOR—NGF signalling via TRKA from the plasma membrane—AKT1—Alzheimer's disease	5.54e-05	0.000251	CbGpPWpGaD
Pimecrolimus—FKBP1A—Signaling Pathways—PRKCG—Alzheimer's disease	5.48e-05	0.000248	CbGpPWpGaD
Pimecrolimus—MTOR—Disease—ADAM10—Alzheimer's disease	5.43e-05	0.000246	CbGpPWpGaD
Pimecrolimus—MTOR—Cellular responses to stress—TP53—Alzheimer's disease	5.38e-05	0.000244	CbGpPWpGaD
Pimecrolimus—FKBP1A—Signaling Pathways—NGF—Alzheimer's disease	5.34e-05	0.000242	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling Pathways—NPY—Alzheimer's disease	5.2e-05	0.000236	CbGpPWpGaD
Pimecrolimus—FKBP1A—Signaling Pathways—CCR5—Alzheimer's disease	5.2e-05	0.000235	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling Pathways—IAPP—Alzheimer's disease	5.17e-05	0.000234	CbGpPWpGaD
Pimecrolimus—MTOR—Innate Immune System—BCL2—Alzheimer's disease	5.09e-05	0.000231	CbGpPWpGaD
Pimecrolimus—FKBP1A—Signaling Pathways—HTR2A—Alzheimer's disease	5.09e-05	0.00023	CbGpPWpGaD
Pimecrolimus—FKBP1A—Disease—NOS3—Alzheimer's disease	5.06e-05	0.000229	CbGpPWpGaD
Pimecrolimus—MTOR—Immune System—IL1A—Alzheimer's disease	5.03e-05	0.000228	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling Pathways—CRH—Alzheimer's disease	5.01e-05	0.000227	CbGpPWpGaD
Pimecrolimus—CYP3A4—Metabolism—DHCR24—Alzheimer's disease	5e-05	0.000226	CbGpPWpGaD
Pimecrolimus—MTOR—Cellular responses to stress—IL6—Alzheimer's disease	4.93e-05	0.000223	CbGpPWpGaD
Pimecrolimus—MTOR—Immune System—MEF2C—Alzheimer's disease	4.86e-05	0.00022	CbGpPWpGaD
Pimecrolimus—MTOR—Immune System—AGER—Alzheimer's disease	4.82e-05	0.000218	CbGpPWpGaD
Pimecrolimus—MTOR—Immune System—PRKCG—Alzheimer's disease	4.77e-05	0.000216	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling Pathways—NPS—Alzheimer's disease	4.75e-05	0.000215	CbGpPWpGaD
Pimecrolimus—FKBP1A—Signaling Pathways—CALM1—Alzheimer's disease	4.74e-05	0.000215	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling Pathways—PPP3CA—Alzheimer's disease	4.73e-05	0.000214	CbGpPWpGaD
Pimecrolimus—FKBP1A—Signaling Pathways—LEP—Alzheimer's disease	4.73e-05	0.000214	CbGpPWpGaD
Pimecrolimus—FKBP1A—Signaling Pathways—APOE—Alzheimer's disease	4.73e-05	0.000214	CbGpPWpGaD
Pimecrolimus—FKBP1A—Signaling Pathways—CAV1—Alzheimer's disease	4.68e-05	0.000212	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling Pathways—PTK2B—Alzheimer's disease	4.66e-05	0.000211	CbGpPWpGaD
Pimecrolimus—FKBP1A—Disease—PTGS2—Alzheimer's disease	4.63e-05	0.00021	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling by NGF—IL6—Alzheimer's disease	4.62e-05	0.000209	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling Pathways—GAB2—Alzheimer's disease	4.54e-05	0.000205	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling Pathways—NTRK2—Alzheimer's disease	4.54e-05	0.000205	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling Pathways—SST—Alzheimer's disease	4.54e-05	0.000205	CbGpPWpGaD
Pimecrolimus—MTOR—Disease—LPL—Alzheimer's disease	4.53e-05	0.000205	CbGpPWpGaD
Pimecrolimus—FKBP1A—Signaling Pathways—ESR1—Alzheimer's disease	4.51e-05	0.000205	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling Pathways—GSK3A—Alzheimer's disease	4.5e-05	0.000204	CbGpPWpGaD
Pimecrolimus—FKBP1A—Signaling Pathways—F2—Alzheimer's disease	4.46e-05	0.000202	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling Pathways—APP—Alzheimer's disease	4.42e-05	0.0002	CbGpPWpGaD
Pimecrolimus—MTOR—Disease—PRKCG—Alzheimer's disease	4.4e-05	0.0002	CbGpPWpGaD
Pimecrolimus—FKBP1A—Signaling Pathways—NOTCH1—Alzheimer's disease	4.36e-05	0.000198	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling by NGF—AKT1—Alzheimer's disease	4.26e-05	0.000193	CbGpPWpGaD
Pimecrolimus—CYP3A4—Metabolism—CA4—Alzheimer's disease	4.25e-05	0.000193	CbGpPWpGaD
Pimecrolimus—MTOR—Disease—CCR5—Alzheimer's disease	4.17e-05	0.000189	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling Pathways—PLCB1—Alzheimer's disease	4.17e-05	0.000189	CbGpPWpGaD
Pimecrolimus—MTOR—Innate Immune System—MAPK8—Alzheimer's disease	4.13e-05	0.000187	CbGpPWpGaD
Pimecrolimus—MTOR—Immune System—CALM1—Alzheimer's disease	4.13e-05	0.000187	CbGpPWpGaD
Pimecrolimus—FKBP1A—Signaling Pathways—GSK3B—Alzheimer's disease	4.09e-05	0.000186	CbGpPWpGaD
Pimecrolimus—MTOR—Disease—MTHFR—Alzheimer's disease	4.08e-05	0.000185	CbGpPWpGaD
Pimecrolimus—FKBP1A—Signaling Pathways—CREB1—Alzheimer's disease	4.06e-05	0.000184	CbGpPWpGaD
Pimecrolimus—FKBP1A—Signaling Pathways—INS—Alzheimer's disease	4.04e-05	0.000183	CbGpPWpGaD
Pimecrolimus—CYP3A4—Metabolism—GAPDHS—Alzheimer's disease	4e-05	0.000181	CbGpPWpGaD
Pimecrolimus—FKBP1A—Signaling Pathways—CCL2—Alzheimer's disease	3.97e-05	0.00018	CbGpPWpGaD
Pimecrolimus—FKBP1A—Signaling Pathways—IGF1—Alzheimer's disease	3.91e-05	0.000177	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling Pathways—NGFR—Alzheimer's disease	3.89e-05	0.000176	CbGpPWpGaD
Pimecrolimus—MTOR—Disease—CALM1—Alzheimer's disease	3.81e-05	0.000173	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling Pathways—ADAM10—Alzheimer's disease	3.8e-05	0.000172	CbGpPWpGaD
Pimecrolimus—MTOR—Disease—APOE—Alzheimer's disease	3.8e-05	0.000172	CbGpPWpGaD
Pimecrolimus—CYP3A4—Metabolism—ATP5A1—Alzheimer's disease	3.79e-05	0.000172	CbGpPWpGaD
Pimecrolimus—MTOR—Disease—CAV1—Alzheimer's disease	3.76e-05	0.00017	CbGpPWpGaD
Pimecrolimus—CYP3A4—Metabolism—PLD3—Alzheimer's disease	3.61e-05	0.000164	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling Pathways—S100B—Alzheimer's disease	3.59e-05	0.000163	CbGpPWpGaD
Pimecrolimus—MTOR—Immune System—GSK3B—Alzheimer's disease	3.56e-05	0.000161	CbGpPWpGaD
Pimecrolimus—FKBP1A—Signaling Pathways—NOS3—Alzheimer's disease	3.54e-05	0.00016	CbGpPWpGaD
Pimecrolimus—MTOR—Disease—NOS2—Alzheimer's disease	3.54e-05	0.00016	CbGpPWpGaD
Pimecrolimus—MTOR—Immune System—CREB1—Alzheimer's disease	3.53e-05	0.00016	CbGpPWpGaD
Pimecrolimus—MTOR—Disease—NOTCH1—Alzheimer's disease	3.5e-05	0.000159	CbGpPWpGaD
Pimecrolimus—CYP3A4—Metabolism—HSD17B10—Alzheimer's disease	3.46e-05	0.000157	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling Pathways—IGF2—Alzheimer's disease	3.42e-05	0.000155	CbGpPWpGaD
Pimecrolimus—FKBP1A—Disease—TGFB1—Alzheimer's disease	3.34e-05	0.000152	CbGpPWpGaD
Pimecrolimus—CYP3A4—Metabolism—CYP46A1—Alzheimer's disease	3.33e-05	0.000151	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling Pathways—IGF1R—Alzheimer's disease	3.31e-05	0.00015	CbGpPWpGaD
Pimecrolimus—MTOR—Disease—GSK3B—Alzheimer's disease	3.29e-05	0.000149	CbGpPWpGaD
Pimecrolimus—MTOR—Disease—CREB1—Alzheimer's disease	3.26e-05	0.000148	CbGpPWpGaD
Pimecrolimus—MTOR—Disease—INS—Alzheimer's disease	3.24e-05	0.000147	CbGpPWpGaD
Pimecrolimus—CYP3A4—Metabolism—ND1—Alzheimer's disease	3.22e-05	0.000146	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling Pathways—LPL—Alzheimer's disease	3.17e-05	0.000144	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling Pathways—MEF2C—Alzheimer's disease	3.14e-05	0.000142	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling Pathways—PRKCG—Alzheimer's disease	3.08e-05	0.00014	CbGpPWpGaD
Pimecrolimus—FKBP1A—Signaling Pathways—CASP3—Alzheimer's disease	3.01e-05	0.000136	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling Pathways—NGF—Alzheimer's disease	3e-05	0.000136	CbGpPWpGaD
Pimecrolimus—MTOR—Immune System—BCL2—Alzheimer's disease	2.97e-05	0.000134	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling Pathways—CCR5—Alzheimer's disease	2.92e-05	0.000132	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling Pathways—HTR2A—Alzheimer's disease	2.86e-05	0.00013	CbGpPWpGaD
Pimecrolimus—MTOR—Disease—NOS3—Alzheimer's disease	2.84e-05	0.000129	CbGpPWpGaD
Pimecrolimus—FKBP1A—Signaling Pathways—MAPK8—Alzheimer's disease	2.76e-05	0.000125	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling Pathways—CALM1—Alzheimer's disease	2.67e-05	0.000121	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling Pathways—LEP—Alzheimer's disease	2.66e-05	0.00012	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling Pathways—APOE—Alzheimer's disease	2.66e-05	0.00012	CbGpPWpGaD
Pimecrolimus—MTOR—Innate Immune System—IL6—Alzheimer's disease	2.64e-05	0.000119	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling Pathways—CAV1—Alzheimer's disease	2.63e-05	0.000119	CbGpPWpGaD
Pimecrolimus—MTOR—Immune System—IL1B—Alzheimer's disease	2.62e-05	0.000119	CbGpPWpGaD
Pimecrolimus—MTOR—Disease—PTGS2—Alzheimer's disease	2.6e-05	0.000118	CbGpPWpGaD
Pimecrolimus—FKBP1A—Signaling Pathways—VEGFA—Alzheimer's disease	2.55e-05	0.000116	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling Pathways—ESR1—Alzheimer's disease	2.54e-05	0.000115	CbGpPWpGaD
Pimecrolimus—FKBP1A—Disease—IL6—Alzheimer's disease	2.52e-05	0.000114	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling Pathways—F2—Alzheimer's disease	2.51e-05	0.000114	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling Pathways—NOTCH1—Alzheimer's disease	2.45e-05	0.000111	CbGpPWpGaD
Pimecrolimus—MTOR—Innate Immune System—AKT1—Alzheimer's disease	2.43e-05	0.00011	CbGpPWpGaD
Pimecrolimus—MTOR—Immune System—MAPK8—Alzheimer's disease	2.4e-05	0.000109	CbGpPWpGaD
Pimecrolimus—FKBP1A—Signaling Pathways—TGFB1—Alzheimer's disease	2.34e-05	0.000106	CbGpPWpGaD
Pimecrolimus—MTOR—Adaptive Immune System—AKT1—Alzheimer's disease	2.33e-05	0.000106	CbGpPWpGaD
Pimecrolimus—FKBP1A—Disease—AKT1—Alzheimer's disease	2.32e-05	0.000105	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling Pathways—GSK3B—Alzheimer's disease	2.3e-05	0.000104	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling Pathways—CREB1—Alzheimer's disease	2.28e-05	0.000103	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling Pathways—INS—Alzheimer's disease	2.27e-05	0.000103	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling Pathways—CCL2—Alzheimer's disease	2.23e-05	0.000101	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling Pathways—IGF1—Alzheimer's disease	2.2e-05	9.96e-05	CbGpPWpGaD
Pimecrolimus—CYP3A4—Metabolism—TPI1—Alzheimer's disease	2.08e-05	9.4e-05	CbGpPWpGaD
Pimecrolimus—CYP3A4—Metabolism—CHAT—Alzheimer's disease	2.08e-05	9.4e-05	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling Pathways—NOS3—Alzheimer's disease	1.99e-05	9.03e-05	CbGpPWpGaD
Pimecrolimus—CYP3A4—Metabolism—MAOB—Alzheimer's disease	1.99e-05	9.02e-05	CbGpPWpGaD
Pimecrolimus—FKBP1A—Signaling Pathways—TP53—Alzheimer's disease	1.93e-05	8.74e-05	CbGpPWpGaD
Pimecrolimus—CYP3A4—Metabolism—GAPDH—Alzheimer's disease	1.92e-05	8.68e-05	CbGpPWpGaD
Pimecrolimus—MTOR—Disease—TGFB1—Alzheimer's disease	1.88e-05	8.52e-05	CbGpPWpGaD
Pimecrolimus—CYP3A4—Metabolism—A2M—Alzheimer's disease	1.85e-05	8.38e-05	CbGpPWpGaD
Pimecrolimus—FKBP1A—Signaling Pathways—IL6—Alzheimer's disease	1.76e-05	8e-05	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling Pathways—CASP3—Alzheimer's disease	1.69e-05	7.66e-05	CbGpPWpGaD
Pimecrolimus—FKBP1A—Signaling Pathways—AKT1—Alzheimer's disease	1.63e-05	7.38e-05	CbGpPWpGaD
Pimecrolimus—CYP3A4—Metabolism—ACHE—Alzheimer's disease	1.61e-05	7.29e-05	CbGpPWpGaD
Pimecrolimus—CYP3A4—Metabolism—INPP5D—Alzheimer's disease	1.59e-05	7.21e-05	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling Pathways—MAPK8—Alzheimer's disease	1.55e-05	7.04e-05	CbGpPWpGaD
Pimecrolimus—MTOR—Immune System—IL6—Alzheimer's disease	1.54e-05	6.96e-05	CbGpPWpGaD
Pimecrolimus—CYP3A4—Metabolism—ENO1—Alzheimer's disease	1.51e-05	6.83e-05	CbGpPWpGaD
Pimecrolimus—CYP3A4—Metabolism—PTGS1—Alzheimer's disease	1.51e-05	6.83e-05	CbGpPWpGaD
Pimecrolimus—CYP3A4—Metabolism—CYP2D6—Alzheimer's disease	1.48e-05	6.7e-05	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling Pathways—VEGFA—Alzheimer's disease	1.44e-05	6.5e-05	CbGpPWpGaD
Pimecrolimus—MTOR—Disease—IL6—Alzheimer's disease	1.42e-05	6.42e-05	CbGpPWpGaD
Pimecrolimus—MTOR—Immune System—AKT1—Alzheimer's disease	1.42e-05	6.42e-05	CbGpPWpGaD
Pimecrolimus—CYP3A4—Metabolism—BCHE—Alzheimer's disease	1.4e-05	6.35e-05	CbGpPWpGaD
Pimecrolimus—CYP3A4—Metabolism—PLCB1—Alzheimer's disease	1.32e-05	5.99e-05	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling Pathways—TGFB1—Alzheimer's disease	1.32e-05	5.97e-05	CbGpPWpGaD
Pimecrolimus—MTOR—Disease—AKT1—Alzheimer's disease	1.31e-05	5.92e-05	CbGpPWpGaD
Pimecrolimus—CYP3A4—Metabolism—ABCA1—Alzheimer's disease	1.28e-05	5.81e-05	CbGpPWpGaD
Pimecrolimus—CYP3A4—Metabolism—PPARGC1A—Alzheimer's disease	1.11e-05	5.01e-05	CbGpPWpGaD
Pimecrolimus—CYP3A4—Metabolism—HMOX1—Alzheimer's disease	1.1e-05	4.98e-05	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling Pathways—TP53—Alzheimer's disease	1.08e-05	4.91e-05	CbGpPWpGaD
Pimecrolimus—CYP3A4—Metabolism—LPL—Alzheimer's disease	1.01e-05	4.56e-05	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling Pathways—IL6—Alzheimer's disease	9.93e-06	4.5e-05	CbGpPWpGaD
Pimecrolimus—MTOR—Signaling Pathways—AKT1—Alzheimer's disease	9.16e-06	4.15e-05	CbGpPWpGaD
Pimecrolimus—CYP3A4—Metabolism—MTHFR—Alzheimer's disease	9.06e-06	4.1e-05	CbGpPWpGaD
Pimecrolimus—CYP3A4—Metabolism—CALM1—Alzheimer's disease	8.46e-06	3.84e-05	CbGpPWpGaD
Pimecrolimus—CYP3A4—Metabolism—APOE—Alzheimer's disease	8.43e-06	3.82e-05	CbGpPWpGaD
Pimecrolimus—CYP3A4—Metabolism—CAV1—Alzheimer's disease	8.36e-06	3.79e-05	CbGpPWpGaD
Pimecrolimus—CYP3A4—Metabolism—PPARG—Alzheimer's disease	7.35e-06	3.33e-05	CbGpPWpGaD
Pimecrolimus—CYP3A4—Metabolism—INS—Alzheimer's disease	7.21e-06	3.26e-05	CbGpPWpGaD
Pimecrolimus—CYP3A4—Metabolism—NOS3—Alzheimer's disease	6.32e-06	2.86e-05	CbGpPWpGaD
Pimecrolimus—CYP3A4—Metabolism—PTGS2—Alzheimer's disease	5.78e-06	2.62e-05	CbGpPWpGaD
Pimecrolimus—CYP3A4—Metabolism—AKT1—Alzheimer's disease	2.9e-06	1.32e-05	CbGpPWpGaD
